Top Markets
Coin of the day
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Pozycja w akcjach #12591
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Cena akcji
$9.09
Ostatnia synchronizacja: 2023-06-23
Kapitalizacja rynkowa
$567.77M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel CTI BioPharma Corp. (CTIC)

Kategoria

Historia ceny akcji dla CTI BioPharma Corp. (CTIC)
Najwyższa cena zamknięcia: $9.07 dnia 2023-06-01

Najniższa cena zamknięcia: $121.75K dnia 1997-03-01
Historia cen akcji firmy CTI BioPharma Corp. od 1997 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 59.07%
2022 173.23%
2021 -38.21%
2020 161.00%
2019 5.88%
2018 -53.69%
2017 -42.12%
2016 -61.16%
2015 -49.72%
2014 27.27%
2013 38.57%
2012 -76.52%
2011 -49.34%
2010 -67.69%
2009 680.34%
2008 -99.33%
2007 -70.14%
2006 -20.03%
2005 -71.45%
2004 -4.83%
2003 6.48%
2002 -68.99%
2001 -35.93%
2000 997.50%
1999 22.69%
1998 -81.36%
1997 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$759.27 7.20%
CH